Myomo, Inc. (MYO)
- Previous Close
3.4200 - Open
3.4300 - Bid 3.3600 x 900
- Ask 3.6100 x 1200
- Day's Range
3.3600 - 3.5100 - 52 Week Range
0.3710 - 5.5800 - Volume
158,538 - Avg. Volume
279,015 - Market Cap (intraday)
97.711M - Beta (5Y Monthly) 1.53
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2800 - Earnings Date May 8, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
5.50
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
myomo.comRecent News: MYO
Performance Overview: MYO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MYO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MYO
Valuation Measures
Market Cap
97.71M
Enterprise Value
89.45M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.26
Price/Book (mrq)
10.87
Enterprise Value/Revenue
4.65
Enterprise Value/EBITDA
-11.60
Financial Highlights
Profitability and Income Statement
Profit Margin
-42.34%
Return on Assets (ttm)
-41.58%
Return on Equity (ttm)
-106.17%
Revenue (ttm)
19.24M
Net Income Avi to Common (ttm)
-8.15M
Diluted EPS (ttm)
-0.2800
Balance Sheet and Cash Flow
Total Cash (mrq)
8.87M
Total Debt/Equity (mrq)
6.69%
Levered Free Cash Flow (ttm)
-2.83M